Log in to save to my catalogue

Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emi...

Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3c6a9f80d386460cb4be379410216bea

Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates

About this item

Full title

Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates

Publisher

London, England: SAGE Publications

Journal title

Therapeutic advances in gastroenterology, 2021-12, Vol.14, p.17562848211065329-17562848211065329

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Background:
Inflammatory bowel diseases (IBD) are chronic, relapsing-remitting inflammatory conditions with a substantial negative impact on health-related quality of life and work productivity. Treatment of IBD has been revolutionized by the advent of biologic therapies, initially with anti-TNF agents and more recently with multiple alternative...

Alternative Titles

Full title

Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3c6a9f80d386460cb4be379410216bea

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3c6a9f80d386460cb4be379410216bea

Other Identifiers

ISSN

1756-2848,1756-283X

E-ISSN

1756-2848

DOI

10.1177/17562848211065329

How to access this item